Prolactinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m (→Gender) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}, {{Anmol}}, {{Faizan}} | {{CMG}} {{AE}}, {{Anmol}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
45% of [[pituitary adenoma]] are [[prolactinoma]], making it the most common of all [[pituitary adenoma]].<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | |||
The prevalence of [[prolactinoma]] in age group <20 years is 100 per 1,000,000 individuals worldwide. | |||
[[Prolactinoma]] most commomly affects age group 20 to 50 years. | [[Prolactinoma]] most commomly affects age group 20 to 50 years. | ||
| Line 11: | Line 13: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
* | *Worldwide, the prevalence of sporadic [[prolactinoma]] is 6 to 10 per 100,000 persons.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
*The [[prevalence]] of [[prolactinoma]] in age group <20 years is 100 per 1,000,000 individuals worldwide. | |||
*Clinically significant [[pituitary tumors]] affect the health of approximately 14 out of 100,000 people in United States. | *Clinically significant [[pituitary tumors]] affect the health of approximately 14 out of 100,000 people in United States. | ||
*Some [[growth hormone]] producing tumors also co-secrete [[prolactin]]. | *Some [[growth hormone]] producing tumors also co-secrete [[prolactin]]. | ||
*Microprolactinoma are much more common than macroprolactinoma. | *Microprolactinoma are much more common than macroprolactinoma. | ||
===Incidence=== | |||
*Worldwide, the incidence of sporadic [[prolactinoma]] is 0.6 to 1.0 per 100,000 persons per year.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | |||
===Age=== | ===Age=== | ||
Age specific distribution of [[prolactinoma]] is as follows:<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref><ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | |||
*Prolactinoma occur less commonly in age <20 years. | *[[Prolactinoma]] commonly affects individuals of age 20 to 50 years. | ||
*[[Prolactinoma]] occur less commonly in age <20 years with a prevalence of 100 per, 1,000,000 individuals. These tumors accounts for <2% of intracranial tumors among this age group. | |||
===Gender=== | ===Gender=== | ||
* | *women usually have microprolactinoma whereas men usually have macroadenoma. | ||
*Gender wise frequency of prolactinoma depends on age of individual: | *Gender wise frequency of [[prolactinoma]] depends on age of individual: | ||
**Age group - 20 to 50 years | **Age group - 20 to 50 years | ||
***Women are more commonly affected by prolactinoma than men. The women to men ratio is approximately 10:1.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ***Women are more commonly affected by [[prolactinoma]] than men. The women to men ratio is approximately 10:1.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
***The highest prevalance of prolactinoma in women is in age group 20 to 30 years with a women to men ratio of approximately 14:1. | ***The highest prevalance of [[prolactinoma]] in women is in age group 20 to 30 years with a women to men ratio of approximately 14:1. | ||
**Age group >50 years | **Age group >50 years<ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | ||
***Men and women are affected equally after age 50 years. | |||
***Prevalance of prolactinoma increases with age in men after age 50 years which peaks during age group 60 to 70 years. At this time women to men ratio is 1:3. | ***Prevalance of [[prolactinoma]] increases with age in men after age 50 years which peaks during age group 60 to 70 years. At this time women to men ratio is 1:3. | ||
Revision as of 13:39, 21 July 2017
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics |
|
Risk calculators and risk factors for Prolactinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: , Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]
Overview
45% of pituitary adenoma are prolactinoma, making it the most common of all pituitary adenoma.[1]
The prevalence of prolactinoma in age group <20 years is 100 per 1,000,000 individuals worldwide.
Prolactinoma most commomly affects age group 20 to 50 years.
Prolactinoma is more common in females than males in age group 20 to 50 years. Frequency becomes similar after age 50 years.
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of sporadic prolactinoma is 6 to 10 per 100,000 persons.[1]
- The prevalence of prolactinoma in age group <20 years is 100 per 1,000,000 individuals worldwide.
- Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States.
- Some growth hormone producing tumors also co-secrete prolactin.
- Microprolactinoma are much more common than macroprolactinoma.
Incidence
- Worldwide, the incidence of sporadic prolactinoma is 0.6 to 1.0 per 100,000 persons per year.[1]
Age
Age specific distribution of prolactinoma is as follows:[1][2]
- Prolactinoma commonly affects individuals of age 20 to 50 years.
- Prolactinoma occur less commonly in age <20 years with a prevalence of 100 per, 1,000,000 individuals. These tumors accounts for <2% of intracranial tumors among this age group.
Gender
- women usually have microprolactinoma whereas men usually have macroadenoma.
- Gender wise frequency of prolactinoma depends on age of individual:
- Age group - 20 to 50 years
- Women are more commonly affected by prolactinoma than men. The women to men ratio is approximately 10:1.[1]
- The highest prevalance of prolactinoma in women is in age group 20 to 30 years with a women to men ratio of approximately 14:1.
- Age group >50 years[2]
- Men and women are affected equally after age 50 years.
- Prevalance of prolactinoma increases with age in men after age 50 years which peaks during age group 60 to 70 years. At this time women to men ratio is 1:3.
- Age group - 20 to 50 years
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.
- ↑ 2.0 2.1 Mindermann T, Wilson CB (1994). "Age-related and gender-related occurrence of pituitary adenomas". Clin Endocrinol (Oxf). 41 (3): 359–64. PMID 7893282.